HEADER OXIDOREDUCTASE 20-FEB-08 3CAQ TITLE CRYSTAL STRUCTURE OF 5BETA-REDUCTASE (AKR1D1) IN COMPLEX WITH NADPH COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-OXO-5-BETA-STEROID 4-DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DELTA(4)-3-KETOSTEROID 5-BETA-REDUCTASE, ALDO-KETO REDUCTASE COMPND 5 FAMILY 1 MEMBER D1; COMPND 6 EC: 1.3.1.3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 GENE: AKR1D1, SRD5B1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYS; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PGEX6P1 KEYWDS 5B-REDUCTASE, 5BETA-REDUCTASE, 5B-RED, AKR1D1, AKR, ALDO-KETO KEYWDS 2 REDUCTASE, NADP, ANDROSTENEDIONE, NADPH, 5B-DHP, SUBSTRATE KEYWDS 3 INHIBITION, BILE ACID CATABOLISM, CYTOPLASM, DISEASE MUTATION, LIPID KEYWDS 4 METABOLISM, OXIDOREDUCTASE, STEROID METABOLISM EXPDTA X-RAY DIFFRACTION AUTHOR F.FAUCHER,L.CANTIN,R.BRETON REVDAT 4 21-FEB-24 3CAQ 1 REMARK REVDAT 3 24-JAN-18 3CAQ 1 AUTHOR REVDAT 2 23-DEC-08 3CAQ 1 JRNL REVDAT 1 09-DEC-08 3CAQ 0 JRNL AUTH F.FAUCHER,L.CANTIN,V.LUU-THE,F.LABRIE,R.BRETON JRNL TITL CRYSTAL STRUCTURES OF HUMAN DELTA4-3-KETOSTEROID JRNL TITL 2 5BETA-REDUCTASE (AKR1D1) REVEAL THE PRESENCE OF AN JRNL TITL 3 ALTERNATIVE BINDING SITE RESPONSIBLE FOR SUBSTRATE JRNL TITL 4 INHIBITION (DAGGER) (,) (DOUBLE DAGGER). JRNL REF BIOCHEMISTRY V. 47 13537 2008 JRNL REFN ISSN 0006-2960 JRNL PMID 19075558 JRNL DOI 10.1021/BI801276H REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2673653.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 36835 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1854 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5685 REMARK 3 BIN R VALUE (WORKING SET) : 0.2590 REMARK 3 BIN FREE R VALUE : 0.3080 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 304 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5246 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 132 REMARK 3 SOLVENT ATOMS : 278 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.97 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.24000 REMARK 3 B22 (A**2) : 2.97000 REMARK 3 B33 (A**2) : -7.21000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.30 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.870 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.140 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.740 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.740 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.400 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 31.14 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : LIGANDS_.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : LIGANDS_.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3CAQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-FEB-08. REMARK 100 THE DEPOSITION ID IS D_1000046550. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-FEB-07; NULL REMARK 200 TEMPERATURE (KELVIN) : 100; NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N; NULL REMARK 200 RADIATION SOURCE : ROTATING ANODE; NULL REMARK 200 BEAMLINE : NULL; NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418; NULL REMARK 200 MONOCHROMATOR : NULL; NULL REMARK 200 OPTICS : MIRRORS; NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE; NULL REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36835 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 19.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : 0.07400 REMARK 200 FOR THE DATA SET : 16.0800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.56 REMARK 200 R MERGE FOR SHELL (I) : 0.28900 REMARK 200 R SYM FOR SHELL (I) : 0.28700 REMARK 200 FOR SHELL : 4.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG-4000 20%, 0.1M TRIS, 5% MPD, PH REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.19000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.32500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.31500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.32500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.19000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.31500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 465 ASP B 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 3 96.67 91.57 REMARK 500 HIS A 8 43.67 -146.42 REMARK 500 LYS A 30 -32.89 -35.03 REMARK 500 ASN A 60 16.54 -141.33 REMARK 500 ASN A 146 75.08 -150.96 REMARK 500 THR A 224 171.42 74.93 REMARK 500 TRP A 230 -19.84 -157.08 REMARK 500 TRP A 230 -27.42 -157.37 REMARK 500 ASN A 232 85.11 -69.94 REMARK 500 HIS B 8 44.88 -140.45 REMARK 500 ASN B 146 77.74 -151.21 REMARK 500 PHE B 200 78.55 -152.35 REMARK 500 THR B 224 170.87 76.13 REMARK 500 TRP B 230 -14.12 -140.46 REMARK 500 TRP B 230 -11.44 -142.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 219 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 327 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME A 328 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 329 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 330 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 331 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP B 327 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME B 328 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 329 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD B 330 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CAS RELATED DB: PDB REMARK 900 RELATED ID: 3CAV RELATED DB: PDB DBREF 3CAQ A 1 326 UNP P51857 AK1D1_HUMAN 1 326 DBREF 3CAQ B 1 326 UNP P51857 AK1D1_HUMAN 1 326 SEQRES 1 A 326 MET ASP LEU SER ALA ALA SER HIS ARG ILE PRO LEU SER SEQRES 2 A 326 ASP GLY ASN SER ILE PRO ILE ILE GLY LEU GLY THR TYR SEQRES 3 A 326 SER GLU PRO LYS SER THR PRO LYS GLY ALA CYS ALA THR SEQRES 4 A 326 SER VAL LYS VAL ALA ILE ASP THR GLY TYR ARG HIS ILE SEQRES 5 A 326 ASP GLY ALA TYR ILE TYR GLN ASN GLU HIS GLU VAL GLY SEQRES 6 A 326 GLU ALA ILE ARG GLU LYS ILE ALA GLU GLY LYS VAL ARG SEQRES 7 A 326 ARG GLU ASP ILE PHE TYR CYS GLY LYS LEU TRP ALA THR SEQRES 8 A 326 ASN HIS VAL PRO GLU MET VAL ARG PRO THR LEU GLU ARG SEQRES 9 A 326 THR LEU ARG VAL LEU GLN LEU ASP TYR VAL ASP LEU TYR SEQRES 10 A 326 ILE ILE GLU VAL PRO MET ALA PHE LYS PRO GLY ASP GLU SEQRES 11 A 326 ILE TYR PRO ARG ASP GLU ASN GLY LYS TRP LEU TYR HIS SEQRES 12 A 326 LYS SER ASN LEU CYS ALA THR TRP GLU ALA MET GLU ALA SEQRES 13 A 326 CYS LYS ASP ALA GLY LEU VAL LYS SER LEU GLY VAL SER SEQRES 14 A 326 ASN PHE ASN ARG ARG GLN LEU GLU LEU ILE LEU ASN LYS SEQRES 15 A 326 PRO GLY LEU LYS HIS LYS PRO VAL SER ASN GLN VAL GLU SEQRES 16 A 326 CYS HIS PRO TYR PHE THR GLN PRO LYS LEU LEU LYS PHE SEQRES 17 A 326 CYS GLN GLN HIS ASP ILE VAL ILE THR ALA TYR SER PRO SEQRES 18 A 326 LEU GLY THR SER ARG ASN PRO ILE TRP VAL ASN VAL SER SEQRES 19 A 326 SER PRO PRO LEU LEU LYS ASP ALA LEU LEU ASN SER LEU SEQRES 20 A 326 GLY LYS ARG TYR ASN LYS THR ALA ALA GLN ILE VAL LEU SEQRES 21 A 326 ARG PHE ASN ILE GLN ARG GLY VAL VAL VAL ILE PRO LYS SEQRES 22 A 326 SER PHE ASN LEU GLU ARG ILE LYS GLU ASN PHE GLN ILE SEQRES 23 A 326 PHE ASP PHE SER LEU THR GLU GLU GLU MET LYS ASP ILE SEQRES 24 A 326 GLU ALA LEU ASN LYS ASN VAL ARG PHE VAL GLU LEU LEU SEQRES 25 A 326 MET TRP ARG ASP HIS PRO GLU TYR PRO PHE HIS ASP GLU SEQRES 26 A 326 TYR SEQRES 1 B 326 MET ASP LEU SER ALA ALA SER HIS ARG ILE PRO LEU SER SEQRES 2 B 326 ASP GLY ASN SER ILE PRO ILE ILE GLY LEU GLY THR TYR SEQRES 3 B 326 SER GLU PRO LYS SER THR PRO LYS GLY ALA CYS ALA THR SEQRES 4 B 326 SER VAL LYS VAL ALA ILE ASP THR GLY TYR ARG HIS ILE SEQRES 5 B 326 ASP GLY ALA TYR ILE TYR GLN ASN GLU HIS GLU VAL GLY SEQRES 6 B 326 GLU ALA ILE ARG GLU LYS ILE ALA GLU GLY LYS VAL ARG SEQRES 7 B 326 ARG GLU ASP ILE PHE TYR CYS GLY LYS LEU TRP ALA THR SEQRES 8 B 326 ASN HIS VAL PRO GLU MET VAL ARG PRO THR LEU GLU ARG SEQRES 9 B 326 THR LEU ARG VAL LEU GLN LEU ASP TYR VAL ASP LEU TYR SEQRES 10 B 326 ILE ILE GLU VAL PRO MET ALA PHE LYS PRO GLY ASP GLU SEQRES 11 B 326 ILE TYR PRO ARG ASP GLU ASN GLY LYS TRP LEU TYR HIS SEQRES 12 B 326 LYS SER ASN LEU CYS ALA THR TRP GLU ALA MET GLU ALA SEQRES 13 B 326 CYS LYS ASP ALA GLY LEU VAL LYS SER LEU GLY VAL SER SEQRES 14 B 326 ASN PHE ASN ARG ARG GLN LEU GLU LEU ILE LEU ASN LYS SEQRES 15 B 326 PRO GLY LEU LYS HIS LYS PRO VAL SER ASN GLN VAL GLU SEQRES 16 B 326 CYS HIS PRO TYR PHE THR GLN PRO LYS LEU LEU LYS PHE SEQRES 17 B 326 CYS GLN GLN HIS ASP ILE VAL ILE THR ALA TYR SER PRO SEQRES 18 B 326 LEU GLY THR SER ARG ASN PRO ILE TRP VAL ASN VAL SER SEQRES 19 B 326 SER PRO PRO LEU LEU LYS ASP ALA LEU LEU ASN SER LEU SEQRES 20 B 326 GLY LYS ARG TYR ASN LYS THR ALA ALA GLN ILE VAL LEU SEQRES 21 B 326 ARG PHE ASN ILE GLN ARG GLY VAL VAL VAL ILE PRO LYS SEQRES 22 B 326 SER PHE ASN LEU GLU ARG ILE LYS GLU ASN PHE GLN ILE SEQRES 23 B 326 PHE ASP PHE SER LEU THR GLU GLU GLU MET LYS ASP ILE SEQRES 24 B 326 GLU ALA LEU ASN LYS ASN VAL ARG PHE VAL GLU LEU LEU SEQRES 25 B 326 MET TRP ARG ASP HIS PRO GLU TYR PRO PHE HIS ASP GLU SEQRES 26 B 326 TYR HET NDP A 327 48 HET BME A 328 4 HET EDO A 329 4 HET EDO A 330 4 HET MPD A 331 8 HET NDP B 327 48 HET BME B 328 4 HET EDO B 329 4 HET MPD B 330 8 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM BME BETA-MERCAPTOETHANOL HETNAM EDO 1,2-ETHANEDIOL HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NDP 2(C21 H30 N7 O17 P3) FORMUL 4 BME 2(C2 H6 O S) FORMUL 5 EDO 3(C2 H6 O2) FORMUL 7 MPD 2(C6 H14 O2) FORMUL 12 HOH *278(H2 O) HELIX 1 1 GLU A 28 THR A 32 5 5 HELIX 2 2 GLY A 35 GLY A 48 1 14 HELIX 3 3 ALA A 55 GLN A 59 5 5 HELIX 4 4 ASN A 60 GLU A 74 1 15 HELIX 5 5 ARG A 78 ILE A 82 5 5 HELIX 6 6 TRP A 89 HIS A 93 5 5 HELIX 7 7 VAL A 94 GLU A 96 5 3 HELIX 8 8 MET A 97 GLN A 110 1 14 HELIX 9 9 ASN A 146 ALA A 160 1 15 HELIX 10 10 ASN A 172 ASN A 181 1 10 HELIX 11 11 GLN A 202 HIS A 212 1 11 HELIX 12 12 PRO A 237 LYS A 240 5 4 HELIX 13 13 ASP A 241 TYR A 251 1 11 HELIX 14 14 THR A 254 ARG A 266 1 13 HELIX 15 15 ASN A 276 GLN A 285 1 10 HELIX 16 16 THR A 292 ALA A 301 1 10 HELIX 17 17 LEU A 311 ARG A 315 5 5 HELIX 18 18 GLU B 28 THR B 32 5 5 HELIX 19 19 GLY B 35 GLY B 48 1 14 HELIX 20 20 ALA B 55 GLN B 59 5 5 HELIX 21 21 ASN B 60 GLU B 74 1 15 HELIX 22 22 ARG B 78 ILE B 82 5 5 HELIX 23 23 TRP B 89 HIS B 93 5 5 HELIX 24 24 VAL B 94 GLN B 110 1 17 HELIX 25 25 ASN B 146 ALA B 160 1 15 HELIX 26 26 ASN B 172 ASN B 181 1 10 HELIX 27 27 GLN B 202 HIS B 212 1 11 HELIX 28 28 PRO B 237 LYS B 240 5 4 HELIX 29 29 ASP B 241 TYR B 251 1 11 HELIX 30 30 THR B 254 ARG B 266 1 13 HELIX 31 31 ASN B 276 ASN B 283 1 8 HELIX 32 32 THR B 292 ALA B 301 1 10 HELIX 33 33 LEU B 311 ARG B 315 5 5 SHEET 1 A 2 ARG A 9 PRO A 11 0 SHEET 2 A 2 SER A 17 PRO A 19 -1 O ILE A 18 N ILE A 10 SHEET 1 B 8 LEU A 23 GLY A 24 0 SHEET 2 B 8 HIS A 51 ASP A 53 1 O ASP A 53 N LEU A 23 SHEET 3 B 8 PHE A 83 LEU A 88 1 O PHE A 83 N ILE A 52 SHEET 4 B 8 VAL A 114 ILE A 119 1 O LEU A 116 N GLY A 86 SHEET 5 B 8 VAL A 163 SER A 169 1 O LYS A 164 N VAL A 114 SHEET 6 B 8 SER A 191 GLU A 195 1 O SER A 191 N VAL A 168 SHEET 7 B 8 VAL A 215 TYR A 219 1 O TYR A 219 N VAL A 194 SHEET 8 B 8 VAL A 269 VAL A 270 1 O VAL A 269 N ALA A 218 SHEET 1 C 2 ARG B 9 PRO B 11 0 SHEET 2 C 2 SER B 17 PRO B 19 -1 O ILE B 18 N ILE B 10 SHEET 1 D 8 LEU B 23 GLY B 24 0 SHEET 2 D 8 HIS B 51 ASP B 53 1 O ASP B 53 N LEU B 23 SHEET 3 D 8 PHE B 83 LEU B 88 1 O PHE B 83 N ILE B 52 SHEET 4 D 8 VAL B 114 ILE B 119 1 O ILE B 118 N LEU B 88 SHEET 5 D 8 VAL B 163 SER B 169 1 O GLY B 167 N TYR B 117 SHEET 6 D 8 SER B 191 GLU B 195 1 O SER B 191 N VAL B 168 SHEET 7 D 8 VAL B 215 TYR B 219 1 O THR B 217 N VAL B 194 SHEET 8 D 8 VAL B 269 VAL B 270 1 O VAL B 269 N ALA B 218 SITE 1 AC1 31 GLY A 24 THR A 25 TYR A 26 ASP A 53 SITE 2 AC1 31 TYR A 58 SER A 169 ASN A 170 GLN A 193 SITE 3 AC1 31 TYR A 219 SER A 220 PRO A 221 LEU A 222 SITE 4 AC1 31 GLY A 223 THR A 224 SER A 225 ALA A 256 SITE 5 AC1 31 ILE A 271 PRO A 272 LYS A 273 SER A 274 SITE 6 AC1 31 PHE A 275 ARG A 279 GLU A 282 ASN A 283 SITE 7 AC1 31 MPD A 331 HOH A 337 HOH A 344 HOH A 375 SITE 8 AC1 31 HOH A 405 HOH A 450 HOH A 501 SITE 1 AC2 5 ASN A 146 LEU A 147 CYS A 148 LEU A 178 SITE 2 AC2 5 HOH A 446 SITE 1 AC3 3 TYR A 132 TRP A 230 MPD A 331 SITE 1 AC4 7 ASN A 303 LYS A 304 ASN A 305 HOH A 429 SITE 2 AC4 7 HOH A 498 GLN B 59 HIS B 62 SITE 1 AC5 5 TRP A 89 TRP A 230 NDP A 327 EDO A 329 SITE 2 AC5 5 HOH A 337 SITE 1 AC6 31 GLY B 24 THR B 25 TYR B 26 ASP B 53 SITE 2 AC6 31 TYR B 58 LYS B 87 SER B 169 ASN B 170 SITE 3 AC6 31 GLN B 193 TYR B 219 SER B 220 PRO B 221 SITE 4 AC6 31 LEU B 222 GLY B 223 THR B 224 SER B 225 SITE 5 AC6 31 LEU B 239 ALA B 256 ILE B 271 PRO B 272 SITE 6 AC6 31 LYS B 273 SER B 274 PHE B 275 ARG B 279 SITE 7 AC6 31 GLU B 282 ASN B 283 MPD B 330 HOH B 346 SITE 8 AC6 31 HOH B 347 HOH B 380 HOH B 406 SITE 1 AC7 3 CYS B 148 LEU B 178 LYS B 182 SITE 1 AC8 3 TYR B 132 TRP B 230 MPD B 330 SITE 1 AC9 5 ILE B 57 TRP B 89 TRP B 230 NDP B 327 SITE 2 AC9 5 EDO B 329 CRYST1 50.380 110.630 130.650 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019849 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009039 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007654 0.00000